Project Details
Description
Turmeric longa or turmeric has had a long history in Ayurvedic medicine for the treatment of inflammatory conditions. It is made up of three curcuminoids, the main one being curcumin (diferuloylmethane), which has been attributed with anti-inflammatory potential and is responsible for the yellow colour. Supported by several studies, it has been shown to be a pleiotropic molecule capable of modulating multiple cell signalling pathways. It is known to be effective as an adjuvant in the treatment of pathologies such as inflammatory bowel disease, pancreatitis, arthritis, chronic anterior uveitis, and some types of cancer. The other two compounds are Demethoxycurcumin and Bisdemethoxycurcumin.
The aim of our work is to determine the effect of Curcuma Longa as a coadjuvant treatment in patients diagnosed with anterior uveitis.
In this way, we aim to achieve a comprehensive approach to the treatment of a disease that has a major impact worldwide.
The aim of our work is to determine the effect of Curcuma Longa as a coadjuvant treatment in patients diagnosed with anterior uveitis.
In this way, we aim to achieve a comprehensive approach to the treatment of a disease that has a major impact worldwide.
Keywords
Curcumin, Echinacea, Uveitis, Immune System, Inflammation.
| Short title | Curcuma en uveítis anterior |
|---|---|
| Status | Finished |
| Effective start/end date | 2/1/20 → 7/1/20 |
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):
Main Funding Source
- Installed Capacity (Academic Unit)
Location
- Bogotá D.C.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.